Study Summary
This trial tests a new drug combo to see if it helps overweight/obese people lose weight safely.
- Obesity
- Overweight or Obesity
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 47 Secondary · Reporting Duration: At baseline, 24 weeks, 48 weeks
Trial Safety
Safety Progress
Side Effects for
Trial Design
3 Treatment Groups
10 mg/kg bimagrumab
1 of 3
30 mg/kg bimagrumab
1 of 3
Bimagrumab placebo
1 of 3
Experimental Treatment
Non-Treatment Group
450 Total Participants · 3 Treatment Groups
Primary Treatment: 10 mg/kg bimagrumab · Has Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 80 · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
New Jersey | 100.0% |
What portion of applicants met pre-screening criteria?
Did not meet criteria | 100.0% |
Why did patients apply to this trial?
- "I have tried several diet types and exercise but have been unable to lose weight"
How many prior treatments have patients received?
0 | 100.0% |
Frequently Asked Questions
Are recruiting efforts still ongoing for this clinical trial?
"Evidenced by clinicaltrials.gov, this medical study is actively seeking out research participants. The trial was first announced on November 16th 2022 and the most recent changes were implemented February 1st 2023." - Anonymous Online Contributor
Who meets the criteria to enroll in this clinical experiment?
"Eligible participants must meet two criteria: be between 18-80 years old and demonstrate obesity. The trial's recruitment process is ongoing, with an estimated 450 persons sought out for participation." - Anonymous Online Contributor
Can geriatric patients participate in this research endeavor?
"As per the stated eligibility, those who wish to apply must be aged between 18 and 80. For patients younger than 18, there are 218 studies available, whereas 671 exist for participants over 65 years of age." - Anonymous Online Contributor
Does the Food and Drug Administration endorse 10 mg/kg bimagrumab?
"10 mg/kg bimagrumab is considered safe, receiving a rating of 2. This can be attributed to the Phase 2 status of this trial, indicating that while data exists confirming safety, there are no studies yet proving efficacy." - Anonymous Online Contributor
How many sites currently have this experiment underway?
"Currently, the trial is being conducted across 12 sites. These include Cullman, Hialeah and Jacksonville amongst other locations. Selecting a site close to you may be beneficial as it will reduce your travelling burden if participating in this study." - Anonymous Online Contributor
What is the maximum capacity of individuals taking part in this experiment?
"Affirmative. According to the details posted on clinicaltrials.gov, this medical investigation is actively recruiting patients - having been first shared on November 16th 2022 and most recently updated February 1st 2023. The research requires 450 individuals from 12 different sites in order to proceed." - Anonymous Online Contributor
What tangible results is this clinical trial expected to yield?
"This 48-week research project aims to observe the variation in waist circumference (WC) from baseline. Secondary outcomes include absolute change of WC (measured with a non-stretchable tape), changes to lean mass via dual energy X-ray absorptiometry, and percent alteration in fat mass by bioelectrical impedance analysis." - Anonymous Online Contributor